70 filings
6-K
ADCT
Adc Therapeutics SA
14 Dec 20
Current report (foreign)
7:17am
SC 13G
ADCT
Adc Therapeutics SA
10 Dec 20
ADC Therapeutics / FMR ownership change
9:15am
6-K
ADCT
Adc Therapeutics SA
7 Dec 20
Lonca LOTIS 2 subgroup data include updated median duration of response of 12.58 months
7:15am
6-K
ADCT
Adc Therapeutics SA
30 Nov 20
Current report (foreign)
7:22am
6-K
ADCT
Adc Therapeutics SA
20 Nov 20
Current report (foreign)
7:12am
6-K
jbs 9d97m
12 Nov 20
Current report (foreign)
7:07am
6-K
k02hu py44ti
10 Nov 20
ADC Therapeutics to Present at the Stifel 2020 Virtual Healthcare Conference
7:27am
6-K
jeeq1dw
5 Nov 20
ADC Therapeutics to Host Third Quarter 2020
7:26am
6-K
47tbb 2gdtew
4 Nov 20
Updated preliminary data from pivotal Phase 2 trial of camidanlumab tesirine (Cami) in Hodgkin lymphoma selected for oral presentation
11:54am
6-K
uqs 1azr9xf
3 Nov 20
Current report (foreign)
8:01am
6-K
sw2wmx alqunppfr5
30 Oct 20
Current report (foreign)
8:46am
SC 13D/A
e0m4iy gv3inlunv372
13 Oct 20
ADC Therapeutics / AUVEN THERAPEUTICS ownership change
5:26pm
6-K
5u28ern
9 Oct 20
Current report (foreign)
4:19pm
424B4
hiu4fdn4o8
25 Sep 20
Prospectus supplement with pricing info
4:14pm
EFFECT
hdxehyj6 l57yjs
24 Sep 20
Notice of effectiveness
12:15am
POS EX
vu3u90k ml
24 Sep 20
Additional exhibits for listing
12:00am
6-K
tt1dcno
23 Sep 20
Current report (foreign)
8:57pm
6-K
zv0 dx8vka3h3f
21 Sep 20
Current report (foreign)
5:20pm
F-1
z7cdi
21 Sep 20
Registration statement (foreign)
4:30pm
6-K
5o3f4i
21 Sep 20
Current report (foreign)
4:09pm